🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Germany / NCT06012162
Starting soon Observational

Genomics in Heart Transplants

NCT06012162 · tracked via the Priya Life Science Germany tracker
Phase
Observational
Started
2024-01
Last updated
2023-08-25

Condition(s) studied

Heart Transplantation

Study summary

A cross-sectional analysis of 200 heart transplant recipients, combining in-depth phenotyping and risk factor assessment (cardiac MRI, coronary angiogram with OCT, cardiorespiratory exercise tests, exogenic factors like nutrition, smoking, lipid profile) with short-read whole-genome sequencing to elucidate the interplay of established PRS from the literature and exogenic risk factors with respect to HTx outcomes will be carried out.

Besides that, a long-read whole-genome sequencing of 100 newly transplanted recipients and their corresponding donors and extend latest bioinformatics methods developed by the study to analyze long-read data will be performed. This will enable a comprehensive and integrated analysis of structural variants, polygenic risk, high-penetrance variant genotypes, immunogenetic (major and minor histocompatibility), and individual lifestyle risk factors in a unique donor-recipient cohort, elucidating the extent of within-cohort variability and cross-correlations between the considered potential risk factors and an exploratory analysis of the utility of genetic risk scores in light of the study results will be carried out.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patients \> 18 years old undergoing heart transplantation in our centre Exclusion Criteria: * \< 18 years * incapable of giving consent

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
University-Hospital Düsseldorf Division of Cardiology, Pulmonary Disease and Vascular Medicine Düsseldorf Germany

More Heinrich-Heine University, Duesseldorf trials in Germany

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06012162 on ClinicalTrials.gov ↗ ← All trials in Germany